Amyotrophic lateral sclerosis (ALS) associated with superoxide dismutase 1 (SOD1) mutations in British Columbia, Canada : clinical, neurophysiological and neuropathological features

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

  2005cited by this paper
• Amyotrophic Lateral Sclerosis Mortality in the United States, 1979–2001

  2005cited by this paper
• Chapter 10 – Transcranial Magnetic Stimulation in Amyotrophic Lateral Sclerosis

  2005cited by this paper
• Transgenic Small Interfering RNA Halts Amyotrophic Lateral Sclerosis in a Mouse Model*

  2005cited by this paper
• Jean–Martin Charcot (1825–1893)

  2005cited by this paper
• MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX: SURFACE EMG AND SINGLE MOTOR UNIT RESPONSES

  2005cited by this paper
• The Pathobiology of Amyotrophic Lateral Sclerosis: A Proteinopathy?

  2005cited by this paper
• Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS

  2005cited by this paper
• Comparing the function of the corticospinal system in different species: Organizational differences for motor specialization?

  2005cited by this paper
• Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

  2005cited by this paper
• Distal spinal and bulbar muscular atrophy caused by dynactin mutation

  2005cited by this paper
• Virus‐delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis

  2005cited by this paper
• DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

  2004cited by this paper
• Comparative anatomy of the motor system: differences in the organization of corticospinal control in different species

  2004cited by this paper
• Vascular endothelial growth factor and the nervous system

  2004cited by this paper
• Cortical threshold and excitability measurements

  2004cited by this paper
• Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease

  2004cited by this paper
• Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999

  2004cited by this paper
• A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

  2004cited by this paper
• Glial Proliferation and Metabotropic Glutamate Receptor Expression in Amyotrophic Lateral Sclerosis

  2004cited by this paper
• Glutamate receptors: RNA editing and death of motor neurons

  2004cited by this paper
• VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

  2004cited by this paper
• Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.

  2004cited by this paper
• Neuronal Intermediate Filaments

  2004cited by this paper
• siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme.

  2004cited by this paper
• Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND)

  2004cited by this paper
• Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years.

  2003cited by this paper
• VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

  2003cited by this paper
• Chapter 7 Epidemiology of Amyotrophic Lateral Sclerosis/Motor Neuron Disease

  2003cited by this paper
• Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido, Japan: a comparative study.

  2003cited by this paper
• Mutant dynactin in motor neuron disease

  2003cited by this paper
• Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000

  2003cited by this paper
• A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2.

  2003cited by this paper
• Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis.

  2003cited by this paper
• Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q.

  2003cited by this paper
• Transcranial magnetic stimulation.

  2003cited by this paper
• Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998

  2002cited by this paper
• Genetic aspects of amyotrophic lateral sclerosis.

  2002cited by this paper
• Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis

  2002cited by this paper
• ALS and PDC of Guam: Forty-year follow-up

  2002cited by this paper
• Jean-Martin Charcot (1825-1893). The man behind the joint disease.

  2002cited by this paper
• Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.

  2002influential reference
• A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q.

  2002cited by this paper
• Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis.

  2001cited by this paper
• Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis

  2001cited by this paper
• The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis

  2001cited by this paper
• Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS

  2001cited by this paper
• Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis

  2001cited by this paper
• Impaired motor cortical inhibition in Parkinson's disease: motor unit responses to transcranial magnetic stimulation

  2001cited by this paper
• Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

  2001cited by this paper
• The epidemiology of motor neuron diseases: a review of recent studies.

  2001cited by this paper
• Short latency facilitation between pairs of threshold magnetic stimuli studied in amyotrophic lateral sclerosis.

  2001cited by this paper
• How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot.

  2001cited by this paper
• A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2

  2001cited by this paper
• A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2

  2001cited by this paper
• Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis

  2001cited by this paper
• Quantification of upper motor neuron loss in amyotrophic lateral sclerosis.

  2000cited by this paper
• Increasing mortality from amyotrophic lateral sclerosis in Norway?

  2000cited by this paper
• Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders

  2000cited by this paper
• Peristimulus time histograms (PSTHs) – a marker for upper motor neuron involvement in ALS?

  2000influential reference
• Magnetic Stimulation of the Human Nervous System

  2000cited by this paper
• A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4 ) localizes to a 500-kb interval on chromosome 9q34

  2000cited by this paper
• Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22.

  2000cited by this paper
• Corticomotoneuronal activity in ALS: changes in the peristimulus time histogram over time.

  2000cited by this paper
• Assessment of upper and lower motor neurons in Kennedy's disease: Implications for corticomotoneuronal PSTH studies

  1999cited by this paper
• Corticomotoneuronal synaptic connections in normal man: an electrophysiological study.

  1999cited by this paper
• Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence‐based review)

  1999cited by this paper
• Practice Parameter: The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

  1999cited by this paper
• A clinical study of motor evoked potentials using a triple stimulation technique.

  1999cited by this paper
• Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review)

  1999cited by this paper
• Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis.

  1999cited by this paper
• The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals.

  1999cited by this paper
• Mechanism of the silent period following transcranial magnetic stimulation Evidence from epidural recordings

  1999cited by this paper
• Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy

  1999cited by this paper
• Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds.

  1999cited by this paper
• Corticomotoneuronal PSTH studies

  1999influential reference
• Spinal muscular atrophy

  1999cited by this paper
• Transcranial stimulation excites virtually all motor neurons supplying the target muscle. A demonstration and a method improving the study of motor evoked potentials.

  1998cited by this paper
• Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS)

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers

  1998cited by this paper
• Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis

  1998cited by this paper
• Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34.

  1998cited by this paper
• Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis

  1997cited by this paper
• ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

  1997cited by this paper
• Diverse abnormalities of corticomotoneuronal projections in individual patients with amyotrophic lateral sclerosis.

  1997cited by this paper
• Motor evoked potentials (MEPs): evaluation of the different types of responses in amyotrophic lateral sclerosis and primary lateral sclerosis.

  1996cited by this paper
• Association of apolipoprotein E i4 allele with bulbar-onset motor neuron disease

  1996cited by this paper
• Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients.

  1996cited by this paper
• Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease.

  1996cited by this paper
• Double cortical stimulation in amyotrophic lateral sclerosis.

  1996cited by this paper
• Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase

  1995cited by this paper
• An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

  1995cited by this paper
• Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis.

  1995cited by this paper
• Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

  1995cited by this paper
• Comparison of single motor unit responses to transcranial magnetic and peroneal nerve stimulation in the tibialis anterior muscle of patients with amyotrophic lateral sclerosis.

  1995cited by this paper
• Motor neuron disease. Studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation.

  1995cited by this paper
• Apolipoprotein E ϵ4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis

  1995cited by this paper
• Abnormal excitability of the corticospinal pathway in patients with amyotrophic lateral sclerosis: a single motor unit study using transcranial magnetic stimulation.

  1995cited by this paper
• El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis

  1994cited by this paper

• Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis

  2007cites this paper
• Pathogenic Lrrk 2 substitutions and Amyotrophic lateral sclerosis

  2007cites this paper
• Short Communication Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis

  2007cites this paper